These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7446417)

  • 21. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Keefe D; Miura DS
    Am J Cardiol; 1984 Aug; 54(4):37B-42B. PubMed ID: 6465045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Tepper D; Maguire W; Willens H; Keren G; Miura D
    Am J Cardiol; 1984 Aug; 54(4):49B-54B. PubMed ID: 6465047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial uptake and pharmacodynamics of procainamide in patients with coronary heart disease and sustained ventricular tachyarrhythmias.
    Gillis AM; Duff HJ; Mitchell LB; Wyse DG
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1001-6. PubMed ID: 8355178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.
    Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB
    Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of combined treatment with lignocaine, procainamide and practolol in acute myocardial infarction.
    Nordlander R; Nyquist O
    Cardiology; 1980; 66(1):27-42. PubMed ID: 7388852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of procainamide on the inducibility of ventricular tachycardia using programmed stimulation].
    Lukl J; Heinc P; Cernosek B
    Vnitr Lek; 1989 Nov; 35(11):1049-56. PubMed ID: 2623834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous appearance of endocardial late potentials and ability to induce sustained ventricular tachycardia after procainamide administration.
    Gallagher JD; Fernandez J; Maranhao V; Gessman LJ
    J Electrocardiol; 1986 Apr; 19(2):197-201. PubMed ID: 3486933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procainamide for rate control of postsurgical junctional tachycardia.
    Mandapati R; Byrum CJ; Kavey RE; Smith FC; Kveselis DA; Hannan WP; Brandt B; Gaum WE
    Pediatr Cardiol; 2000; 21(2):123-8. PubMed ID: 10754080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes.
    Bhandari AK; Au PK; Rahimtoola SH
    Can J Cardiol; 1986; 2(1):6-9. PubMed ID: 2420424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Termination of ventricular tachycardia: role of tachycardia cycle length.
    Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME
    Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic action of bethanidine.
    Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Wynn J; Keren G; Miura DS
    Am J Cardiol; 1984 Aug; 54(3):343-6. PubMed ID: 6465015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sinusoidal ventricular tachycardia associated with flecainide acetate.
    Sellers TD; DiMarco JP
    Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of ventricular tachycardia in ambulatory patients.
    Winkle RA; Derrington DC; Schroeder JS
    Am J Cardiol; 1977 Apr; 39(4):487-92. PubMed ID: 557893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamics of procainamide in patients with ventricular tachyarrhythmias.
    Liem LB; Yee YG; Swerdlow CD; Kates RE
    J Clin Pharmacol; 1988 Nov; 28(11):984-9. PubMed ID: 3243920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery.
    Gold MR; O'Gara PT; Buckley MJ; DeSanctis RW
    Am J Cardiol; 1996 Nov; 78(9):975-9. PubMed ID: 8916473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of intravenous procainamide during ventricular tachycardia.
    Sharma AD; Purves P; Yee R; Klein G; Jablonsky G; Kostuk WJ
    Am Heart J; 1990 May; 119(5):1034-41. PubMed ID: 2330861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of recurrent symptomatic ventricular tachycardia.
    Winkle RA; Alderman EL; Fitzgerald JW; Harrison DC
    Ann Intern Med; 1976 Jul; 85(1):1-7. PubMed ID: 937905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic effects of indecainide in a drug-resistant population with ventricular tachycardia at programmed electrical stimulation.
    Miura DS; Wynn J; Keefe D; Laux B; Somberg JC
    Am Heart J; 1987 Jan; 113(1):65-9. PubMed ID: 3799443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.